Matches in Wikidata for { <http://www.wikidata.org/entity/Q66402098> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q66402098 description "clinical trial" @default.
- Q66402098 description "ensayu clínicu" @default.
- Q66402098 description "klinisch onderzoek" @default.
- Q66402098 description "клінічне випробування" @default.
- Q66402098 name "Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy" @default.
- Q66402098 name "Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy" @default.
- Q66402098 type Item @default.
- Q66402098 label "Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy" @default.
- Q66402098 label "Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy" @default.
- Q66402098 prefLabel "Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy" @default.
- Q66402098 prefLabel "Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy" @default.
- Q66402098 P1050 Q66402098-1631B2ED-2C04-42C8-BBC2-84362A82E030 @default.
- Q66402098 P1050 Q66402098-8D730F5D-F659-4B6B-8BDE-6E4C1ADE1C3F @default.
- Q66402098 P1050 Q66402098-DF9474F0-3EED-4FB6-96A5-7FA750B3D583 @default.
- Q66402098 P1132 Q66402098-9F322C6F-DF69-4163-AE97-675817B2ADE8 @default.
- Q66402098 P1476 Q66402098-6737ABF3-529F-45BC-8696-C833131A93B3 @default.
- Q66402098 P1813 Q66402098-ED89D8CF-F455-45B8-96E9-C3D0CB2B9C7D @default.
- Q66402098 P3098 Q66402098-914EA1FD-841E-4836-874A-116664031251 @default.
- Q66402098 P31 Q66402098-23A0BC3B-5FA6-451B-8983-53378DDFB81D @default.
- Q66402098 P580 Q66402098-B508921F-3835-44D9-BE20-B5470CF31603 @default.
- Q66402098 P582 Q66402098-7712DF26-B5C5-44F2-8586-326D8984BDFE @default.
- Q66402098 P8363 Q66402098-3B65D4A8-5D60-4DEA-AFED-B2006909A785 @default.
- Q66402098 P859 Q66402098-4D666C93-B3FD-4FAB-92F5-1DA448629686 @default.
- Q66402098 P1050 Q131742 @default.
- Q66402098 P1050 Q157661 @default.
- Q66402098 P1050 Q6853 @default.
- Q66402098 P1132 "+383" @default.
- Q66402098 P1476 "Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Monotherapy: A Retrospective Cohort Study" @default.
- Q66402098 P1813 "NAs resistance" @default.
- Q66402098 P3098 "NCT02791386" @default.
- Q66402098 P31 Q30612 @default.
- Q66402098 P580 "2016-11-22T00:00:00Z" @default.
- Q66402098 P582 "2017-10-30T00:00:00Z" @default.
- Q66402098 P8363 Q818574 @default.
- Q66402098 P859 Q266423 @default.